Q2 2024 saw 3.1% sales growth and improved EBITA, with a fully subscribed rights issue strengthening the balance sheet. Project revaluations weighed on results, but the order book and cash flow improved, supporting a positive outlook.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.